Extrinsic and Intrinsic Factors in Atopic Dermatitis Upon Systemic Immune Modulation
Recruiting
Observational Study
Atopic Dermatitis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 75
- Sex
- Any
- Study type
- Observational
- Participants needed
- 25 (estimated)
- Sponsor
- Charite University, Berlin, Germany · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Currently, patients with moderate to severe atopic dermatitis are treated with dupilumab if unresponsive to topical treatment. However, not all patients who suffer from atopic dermatitis respond similarly to this treatment. Pattern recognition of immune cells (PRI) is an efficient method to screen patients to allow a more personalized therapy.
The main aim of this scientific explorative study is …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 18 and above
* Diagnosis of atopic dermatitis for ≥1 year
* Inadequate response to treatment with topical medications
* Confirmed dupilumab treatment
Exclusion Criteria:
* Age below 18
* Known or suspected allergy or reaction to any component of the dupilumab formulation…
Contacts
No contact information available.